Simvastatin was previously converted to a polymeric prodrug with higher drug loading, but the hydrophobic nature of the poly(simvastatin) component of the block copolymer led to slow release of the drug . In this study, we hypothesized that degradation could be accelerated by chemically modifying the polymer backbone by introducing glycolide and lactide comonomers. Copolymers were formed by ring-opening polymerization using 5 kDa monomethyl ether poly(ethylene glycol) as the microinitiator in presence of triazabicyclodecene catalyst. In addition to simvastatin, modified reaction mixtures contained lactide or glycolide. Incorporation of the less hydrophobic glycolide comonomer led to degradation of up to two times greater mass loss, release of up to ~7 times more simvastatin, and a 2-3 times increase in compressive modulus compared to the lactide-containing and parent polymers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322697 | PMC |
| http://dx.doi.org/10.1021/acsbiomaterials.8b00884 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fabrication and characterizations of simvastatin-containing mesoporous bioactive glass and molybdenum disulfide scaffold for bone tissue engineering.
APL Bioeng
December 2023
Biomaterials Research Laboratory, Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore, Karnataka 575018, India.
Due to the limitations of the current treatment approaches of allograft and autograft techniques, treating bone disorders is a significant challenge. To address these shortcomings, a novel biomaterial composite is required. This study presents the preparation and fabrication of a novel biomaterial composite scaffold that combines poly (D, L-lactide-co-glycolide) (PLGA), mesoporous bioactive glass (MBG), molybdenum disulfide (MoS), and simvastatin (Sim) to address the limitations of current bone grafting techniques of autograft and allograft.
View Article and Find Full Text PDFBiodegradable scaffolds are widely use in drug delivery and tissue engineering applications. The scaffolds can be modified to provide the necessary mechanical support for tissue formation and to deliver one or more drugs to stimulate tissue formation or for the treatment of a specific condition. In the current study, we developed biodegradable scaffolds that have the potential for dual drug delivery.
View Article and Find Full Text PDFBiodegradable polymerized simvastatin stimulates bone formation.
Acta Biomater
July 2019
F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, University of Kentucky, Lexington, KY 40506, USA. Electronic address:
Article Synopsis
- Prior research showed that polymerized simvastatin can release the drug slowly and degrade, which sets the stage for this study that focuses on its effects on bone growth in rats.
- In vivo tests using different simvastatin-containing polymers highlighted that poly(ethylene glycol)-block-poly(simvastatin) resulted in significant new bone growth after four weeks, unlike traditional PLGA which caused bone loss.
- The study suggests that the new polymerized form of simvastatin, due to its slow degradation and controlled inflammation response, holds promise for improving bone regeneration therapies.
Simvastatin With PRP Promotes Chondrogenesis of Bone Marrow Stem Cells In Vitro and Wounded Rat Achilles Tendon-Bone Interface Healing In Vivo.
Am J Sports Med
March 2019
Department of Orthopedics, Jinan Central Hospital Affiliated to Shandong University Medical School, Jinan, China.
Background: Tendons and ligaments are joined to bone in a specialized interface that transmits force from muscle to bone and permits body movement. Tendon/ligament injuries always occur in the interface areas, and injured tendons/ligaments have a limited healing response because the insertion site is composed of a fibrocartilaginous zone.
Purpose: To study the effect of simvastatin with platelet-rich plasma (PRP) on chondrogenesis of rat bone marrow stem cells (BMSCs) in vitro and wounded rat Achilles tendon-bone interface healing in vivo.
Biodegradable Simvastatin-Containing Polymeric Prodrugs with Improved Drug Release.
ACS Biomater Sci Eng
December 2018
F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, 522 Robotics and Manufacturing Building, 143 Graham Avenue, University of Kentucky, Lexington, KY, USA.
Simvastatin was previously converted to a polymeric prodrug with higher drug loading, but the hydrophobic nature of the poly(simvastatin) component of the block copolymer led to slow release of the drug . In this study, we hypothesized that degradation could be accelerated by chemically modifying the polymer backbone by introducing glycolide and lactide comonomers. Copolymers were formed by ring-opening polymerization using 5 kDa monomethyl ether poly(ethylene glycol) as the microinitiator in presence of triazabicyclodecene catalyst.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!